Clinical Trial Update: Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on non-myeloablative bone marrow transplant for sickle cell disease and other blood disorders; study terminated with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Sickle Cell Disease | Phase 2 | Status: TERMINATED | Results posted: 2019-04-17